TABLE 5.
Model | Variable | Odds ratio (95%confidence interval) |
---|---|---|
Patient/Caregiver report of being on hydroxyurea | ||
Age | ||
12 years and younger | Reference | |
13–17 years | 1.9 (0.66–5.2) | |
18–25 years | 0.48 (0.15–1.53) | |
26 years and older | 0.13 (0.04–0.38)** | |
Total Barriers | ||
None | Reference | |
1 barrier | 0.08 (0.03–0.20)*** | |
2 or more barriers | 0.19 (0.07–0.57)* | |
Indication—Recurrent Pain | 811.5 (87.7–7504.3)*** | |
Not Interested in hydroxyurea | 0.06 (0.01–0.31)** | |
Provider prescription of hydroxyurea | ||
Age | ||
12 years and younger | Reference | |
13–17 years | 1.1 (0.56–2.1) | |
18–25 years | 0.65 (0.33–1.30) | |
26 years and older | 0.45 (0.25–0.78)* | |
Total Barriers | ||
None | Reference | |
1 barrier | 0.15 (0.09–0.26)*** | |
2 or more barriers | 0.27 (0.14–0.52)** | |
Diagnosis | ||
HgbSS and HgbSβ0 thalassemia | Reference | |
HgbSC | 0.21 (0.10–0.41)*** | |
Other diagnoses | 0.35 (0.13–0.90) |
*p < 0.01, **p < 0.001, ***p < 0.0001.